Wednesday, December 14, 2011

Biosimilar: Biologics Price Competition and Innovation Act of 2009

Biosimilar: Biologics Price Competition and Innovation Act of 2009
Meeting on Friday, December 16, 2011, from 9 a.m. to 1 p.m.

Agenda: FDA is announcing a public meeting to discuss proposed recommendations for a user fee program for biosimilar biological products (biosimilars user fee program) for FYs 2013 through 2017.